Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2026 07:00 ET | Source: Harrow, Inc.

Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference

NASHVILLE, Tenn., March 04, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will...
March 03, 2026 07:00 ET | Source: Harrow, Inc.

Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication

NASHVILLE, Tenn., March 03, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that the U.S. Food and...
March 02, 2026 16:05 ET | Source: Harrow, Inc.

Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

Fourth Quarter, Full-Year 2025 and Selected Highlights: Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year periodFull-Year revenue of $272.3...
February 18, 2026 07:00 ET | Source: Harrow, Inc.

Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026

NASHVILLE, Tenn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its...
February 17, 2026 07:00 ET | Source: Harrow, Inc.

Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits

NASHVILLE, Tenn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of a new...
February 02, 2026 07:00 ET | Source: Harrow, Inc.

Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth

Doubling of VEVYE® Sales Force is On Track, Expansion of IHEEZO® Commercial Footprint to the Office-Based Setting Underway, and Doubling TRIESENCE® Commercial Footprint in the Surgical-Based Setting...
November 24, 2025 07:00 ET | Source: Harrow, Inc.

Harrow to Present at Two Investor Conferences in December

NASHVILLE, Tenn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will...
November 18, 2025 07:00 ET | Source: Harrow, Inc.

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the...
November 10, 2025 16:05 ET | Source: Harrow, Inc.

Harrow Announces Third Quarter 2025 Financial Results

Third-Quarter 2025 and Recent Selected Highlights: Total revenues of $71.6 million, a 45% increase over $49.3 million recorded in the prior-year periodGAAP net income of $1.0 millionAdjusted EBITDA...
October 27, 2025 07:00 ET | Source: Harrow, Inc.

Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025

NASHVILLE, Tenn., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its...